Sort
64,565 grants matching “drug discovery”
Developmental switches regulating tissue cyst formation
$546,310Michael W White · University Of South Florida · R01 · FY2020 · AI
LATE TRANSITION METAL CATALYSTS FOR ORGANIC SYNTHESIS
$546,245Massachusetts Institute Of Technology · R01 · FY2004 · GM
Discovery and characterization of selective GIRK1/2 activators and their evaluation in preclinical models of pain
$546,237Corey R. Hopkins · University Of Nebraska Medical Center · R01 · FY2025 · NS
Iron independent role for yersiniabactin in Yersinia pestis
$546,234Matthew Lawrenz · University Of Louisville · R01 · FY2022 · AI
HIV Infection of Hematopoietic Progenitor Cells
$546,206Kathleen L Collins · University Of Michigan At Ann Arbor · R01 · FY2013 · AI
Deterrents for prescription opioid abuse
$546,185Kevin B. Freeman · University Of Mississippi Med Ctr · R01 · FY2025 · DA
Strategic Formal [5+2]-Cycloadditions Toward Heteroaryl-fused Seven-membered Rings
$546,154Stefan A France · Georgia Tech Research Corporation · · FY2016 · MPS
Mechanisms of DNA Homology-directed Genome Repair and Tumor Suppression
$546,102Patrick Sung · University Of Texas Hlth Science Center · R35 · FY2019 · CA
ANTICANCER AGENTS FROM UNIQUE NATURAL PRODUCTS SOURCES
$546,001University Of Utah · U19 · FY2000 · CA
Ion Hydration and Nanocalorimetry in Mass Spectrometry
$546,000Evan R Williams · University Of California-Berkeley · · FY2013 · MPS
RNA-based therapeutics for hemostasis and thrombosis
$546,000Lawrence E Goldfinger · Thomas Jefferson University · R33 · FY2024 · HL
RNA-based therapeutics for hemostasis and thrombosis
$545,998Lawrence E Goldfinger · Thomas Jefferson University · R33 · FY2025 · HL
In Vitro Evaluation and Characterization of Novel Lead Therapeutic Candidates for Encephalitic Alphavirus Treatment
$545,850Donghoon Chung · University Of Tennessee Health Sci Ctr · U19 · FY2023 · AI
Microfibril deficiency in glaucoma pathogenesis
$545,795Rachel W Kuchtey · Vanderbilt University · R01 · FY2014 · EY
Protein-Protein Interactions in Natural Product Biosynthesis
$545,790Michael D Burkart · University Of California, San Diego · R01 · FY2021 · GM
Safety and Effectiveness of Medications for Alcohol Use Disorder among HIV+/-
$545,777E. Jennifer Edelman · Yale University · P01 · FY2021 · AA
Type A CCK Receptor Structure, Function & Regulation
$545,758Laurence J Miller · Mayo Clinic Arizona · R01 · FY2011 · DK
Molecular Basis of Human Cytochrome P450 3A Function
$545,752James R Halpert · University Of California, San Diego · R37 · FY2012 · GM
Target discovery and combination therapy in KRAS mutant cancer
$545,711Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
UAB Center for Clinical and Translational Science (CCTS)
$545,701Robert P Kimberly · University Of Alabama At Birmingham · UL1 · FY2017 · TR
Development of tolerogenic Factor VIII as immunotherapy to prevent inhibitor development in Hemophilia A
$545,700Sathy Venkat Balu-Iyer · State University Of New York At Buffalo · R61 · FY2024 · HL
Fluorescent HTS Assays for Human Sulfotransferases
$545,659Bellbrook Labs, Llc · R44 · FY2005 · GM
Design of a Novel Nanocarrier Technology to Drug-Load CAR T cells
$545,643David Akhavan · University Of Kansas Medical Center · R01 · FY2024 · CA
DRILL: Droplet Desolvation and Ion Transmission Interface for Mass Spectrometry
$545,567Andrei G Fedorov · Georgia Institute Of Technology · R01 · FY2015 · GM
DRILL: Droplet Desolvation and Ion Transmission Interface for Mass Spectrometry
$545,567Andrei G Fedorov · Georgia Institute Of Technology · R01 · FY2017 · GM